A Study Evaluating the Use of an Indoor Air Quality Monitor to Promote a Smoke-free Home
Freedom to Breathe: Pilot Study Towards Achieving Environmental Justice for Cancer Patients and Their Families
1 other identifier
interventional
10
1 country
8
Brief Summary
The purpose of this study is to evaluate how using an indoor air quality monitor can promote a smoke-free home for cancer patients who are enrolled in MSK's Tobacco Treatment Program.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2024
Typical duration for not_applicable
8 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 14, 2024
CompletedStudy Start
First participant enrolled
November 14, 2024
CompletedFirst Posted
Study publicly available on registry
November 18, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 14, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 14, 2027
October 22, 2025
October 1, 2025
3 years
November 14, 2024
October 21, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Percentage of participants using the air quality monitoring device for 14 consecutive days
Assess the feasibility and acceptability of collecting environmental data on biomarkers of household air quality (AQ) and smoke exposure using low-cost, AQMs as an intermediate endpoint of a smoke-free-home.
up to 8 weeks
Percentage of participants who attend the study-specific smoke-free workshop sessions
Assess the feasibility and acceptability of tobacco treatment adherence among individuals diagnosed with cancer.
Up to 8 weeks
Study Arms (1)
MSK Participants who are current smokers
EXPERIMENTAL10 MSK participants who are current smokers and receiving tobacco treatment will be enrolled.
Interventions
Participants will be asked to set up an Indoor Air Quality Monitor AirGradient ONE (Model: I-9PSL) which is an award winning commercially available indoor air quality monitor designed to enable anyone to monitor their air quality in their home for about 60 days (8 weeks). Indoor air pollution levels within participating households will be measured using these AQMs.
Eligibility Criteria
You may qualify if:
- Adult (aged \>18 years) MSK patients as per the EHR
- Has been referred and enrolled in the MSK TTP and completed the initial counseling session as per the TTP clinical database
- Reports current (within the past 30 days) tobacco use (i.e., cigarettes and/or any other tobacco products) as per the TTP Intake form
- Must be English-speaking in the EHR
- Must be reachable by phone as per self-report
- Must have Wi-Fi available at home as per self-report
You may not qualify if:
- Patient reports that no smoking is allowed, by them or anyone else, in the home as per the TTP intake form and/or per self-report
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (8)
Memorial Sloan Kettering Basking Ridge (Consent only)
Basking Ridge, New Jersey, 07920, United States
Memorial Sloan Kettering Monmouth (Consent only)
Middletown, New Jersey, 07748, United States
Memorial Sloan Kettering Bergen (Consent only)
Montvale, New Jersey, 07645, United States
Memorial Sloan Kettering Suffolk-Commack (Consent only)
Commack, New York, 11725, United States
Memorial Sloan Kettering Westchester (Consent only)
Harrison, New York, 10604, United States
City College of New York (Data Collection AND Data Analysis)
New York, New York, 10031, United States
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York, New York, 10065, United States
Memorial Sloan Kettering Nassau (Consent only)
Uniondale, New York, 11553, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gleneara Bates-Pappas, PhD, LMSW
Memorial Sloan Kettering Cancer Center
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 14, 2024
First Posted
November 18, 2024
Study Start
November 14, 2024
Primary Completion (Estimated)
November 14, 2027
Study Completion (Estimated)
November 14, 2027
Last Updated
October 22, 2025
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will share
Memorial Sloan Kettering Cancer Center supports the international committee of medical journal editors (ICMJE) and the ethical obligation of responsible sharing of data from clinical trials. The protocol summary, a statistical summary, and informed consent form will be made available on clinicaltrials.gov when required as a condition of Federal awards, other agreements supporting the research and/or as otherwise required. Requests for deidentified individual participant data can be made beginning 12 months after publication and for up to 36 months post publication. Deidentified individual participant data reported in the manuscript will be shared under the terms of a Data Use Agreement and may only be used for approved proposals. Requests may be made to: crdatashare@mskcc.org.